Company news
Bioasis Technologies Inc. news in 2015
Bioasis Technologies Inc.'s news releases, calls and decks from 2015, newest first.
biOasis Announces the Issuance of a US Patent for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier Using Polypeptides Derived From the Transcend Protein Delivery Vector
November 29, 2015
OTC Markets Group Welcomes Newly Verified OTCQB Companies – September 29
September 29, 2015
biOasis Announces Listing on OTCQB Exchange
September 28, 2015
biOasis Announces Extension of Share Purchase Warrants
August 14, 2015
biOasis Announces the Successful Delivery to the CNS of an Enzyme Used to Treat Hunter Syndrome
July 31, 2015
biOasis Technologies Inc. and Brigham and Women's Hospital Inc., Enter a Neuro-Oncology Research & Collaboration Agreement
July 21, 2015
biOasis Engages Kilmer Lucas for Cross-Border Investor Relations
June 8, 2015
biOasis Enters Into A Collaborative Research and Joint Funding Support Agreement Entitled "Focus on Brain"
May 27, 2015
biOasis Provides Scientific Updates on Its Transcend Programs
May 12, 2015
biOasis European Patent Granted for The Use of Transcend for the Delivery of Enzymes to Treat Lysosomal Storage Disease in The Brain
April 21, 2015
biOasis Releases Results From an Ischemic Stroke Model with Transcend BBB Carrier Peptide (MTfp): MTfp-siRNA Reduces Both the Damage Caused by Infarct and Significantly Improves Neurological Score
March 16, 2015
biOasis Announces Grant of Stock Options
January 30, 2015
biOasis Announces the Release of an Analyst Report
January 20, 2015